Peer Review History
| Original SubmissionAugust 5, 2024 |
|---|
|
PONE-D-24-33067 Diversity, distribution, and genetic structure of Escherichia coli in the lower gastrointestinal tract of humans PLOS ONE Dear Dr. Barua, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we have decided that your manuscript does not meet our criteria for publication and must therefore be rejected. I am sorry that we cannot be more positive on this occasion, but hope that you appreciate the reasons for this decision. Kind regards, Mehmet Demirci, PhD Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: Dear Sir A manuscript entitled: "Microbiological profile of sterile site organisms and culture positivity rates from a decade of paediatric admissions at a tertiary hospital in South Africa: A lower and middle-income country perspective" is submitted for publication in the esteemed journal of Plos One. In this manuscript the results of a 10 year survey on blood and CSF cultures from a hospital in South Africa is presented. At first glance, it seems that the manuscript is informative for scientists and physician in the country, and perhaps neighbor countries, and I do not think that it fulfil the insights of international readers. So I suggest it it is better to consider national journals. Also, there are some problems that it is better to be addressed. 1- As the title is indicating, the sterile sites are being studied, which I thought that many other sterile sites are also the subject of this research, but it is limited to only blood and CSF cultures. 2- In several parts of the manuscript it is indicated that this is a retrospective study, which we know that it is not a retrospective 3- I cant understand why CoNS, Viridans group streptococci and Micrococcus were considered as contaminants, which we know that in many cases S. epidermidis is a sepsis causing agent and in many countries viridance streptococci are considered as the most important causative agent of endocarditis, which is originated from sepsis 4- There is a strong stress on different wards of the studied hospital, which is totally unattractive for an international reader 5- The discussion is simply a literature review 6- The conclusion was obvious even without the study Reviewer #2: - Lines 163-166: Language describing isolates from an individual and different strains is slightly confusing, please reword to make easier to understand. - Line 263: typo - Fig 2: 2 Typos in Phylogroup - Can authors comment on any correlation between Fig 5 individual types and antibiotic use ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: Yes: Ramin Abiri Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] - - - - - For journal use only: PONEDEC3 |
| Revision 1 |
|
Escherichia coli Dear Dr. Barua, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jun 15 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Daniel Paredes-Sabja, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well. 3. Please upload a new copy of S1-S4 Figures as the detail is not clear. Please follow the link for more information: "https://blogs.plos.org/plos/2019/06/looking-good-tips-for-creating-your-plos-figures-graphics/"" https://blogs.plos.org/plos/2019/06/looking-good-tips-for-creating-your-plos-figures-graphics/" Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments (if provided): Please note that I have acted as a reviewer for this manuscript, and you will find my comments below, under Reviewer 4. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #3: (No Response) Reviewer #4: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #3: Yes Reviewer #4: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #3: Yes Reviewer #4: I Don't Know ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #3: Yes Reviewer #4: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #3: Yes Reviewer #4: Yes ********** Reviewer #3: This paper was well written, and methods and experiments explained in detail. I have minor comments that are listed below. Introduction - Line 70-71: missing reference “The main niche for E. coli in humans is the lower region of the gut: the ileum, colon, and rectum [ ]” - Line 72-73: in the sentence “The isolation of E. coli strains and their characteristics may vary from region to region in the intestinal tract of pigs [20].”, the mentioning of pigs came out of nowhere. Can you rephrase so the transition be smoother between human and pig research Materials and methods - Line 147: having E clade twice “…A, B1, B2, D, E, F, and E clade.” Why are clade C, G and H not included? - Line 148: having E clade twice “…or E and E clade.” Results - Line 235-239: Maybe a supplementary table will help visualize easier these results of distribution patterns Reviewer #4: Here, authors have molecularly typed a nearly 3300 E. coli isolates from stools and the intestinal mucosa. Overall, this work is well written, and I have minor comments to help improve this work. This work used classical molecular typing tools of a cohort of 46 individuals. Most of the techniques are molecular-based characterization of patterns in MSLT, but authors did not perform DNA sequencing (i.e., sanger or WGS). Many portions of the manuscript invoke the term genetic structure of E. coli strains isolates. I would agree should DNA sequencing not be available; however, current rigor-standard require DNA sequencing to invoke such an interpretation. Please revise entire manuscript and correct accordingly. Title needs to be revised, remove genetic structure, and re-word accordingly. Please put upfront why this study follows up prior work in the introduction. This should improve clarity. Figure 5 please add the legend of each color in the figure. Figure 9: please provide more information of the type of analysis it is not clear to the normal reader. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #3: No Reviewer #4: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org |
| Revision 2 |
|
Escherichia coli Dear Dr. Barua, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jul 28 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Daniel Paredes-Sabja, PhD Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments (if provided): Please address the comments of Reviewer 3 so that the paper can be accepted. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #3: (No Response) Reviewer #4: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #3: Yes Reviewer #4: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #3: Yes Reviewer #4: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #3: Yes Reviewer #4: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #3: Yes Reviewer #4: Yes ********** Reviewer #3: Thank you to the authors for addressing and give detailed explanation to my previous comments. I have an extra few minor comments that are listed below. Previously I commented on why C, G and H phylogroups were not included in the study and authors did a very good job explaining why. - To avoid future confusion of the readers, explain in a briefly manner, why phylogroup C is not present in the study - Why the need of using specific primers to distinguish between phylogroup A and C and the others - And add this. “As we used the Clermont et al. (2013) PCR-based phylotyping method, which classifies only the traditional phylogroups, phylogroups G and H are therefore missing from our analysis.” Introduction - Line 73: Missing reference. … C, E, F, G, and H. [ ] - Line 76: Missing reference … infections in humans. [ ] Materials and methods - Line 145: The PCR step that says elongation should be “annealing” - Line 163: Please add “which is specific for determining the phylogroups” - Line 164: Add the word “between” in � “Specific primers were used to distinguish between phylogroup ….” Discussion - Line 324: Please clarify this sentence “In contrast, the average number of genotypically diverse strains was observed when the dominant strain belonged to phylogroup A, B1, D, and F”. Is the most average number? Higher than the average? Figures and Tables - Fig 2: Extra “o” in phylogroups. Both in legend and Y-axis. Also, move the box where the PValue is depicted elsewhere on the same figure or outside the actual plot because is on top of a 10% value from a phylogroup. - S2 fig: Eliminate extra “0” decimals from Y-axis - S3 Table: Explain what is “Nil” Reviewer #4: The authors have addressed all my comments. I have no further comments on the paper. The new version is elegible and provides rigor ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #3: No Reviewer #4: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org |
| Revision 3 |
|
Diversity, distribution, and population structure of Escherichia coli in the lower gastrointestinal tract of humans PONE-D-24-33067R3 Dear Dr. Barua, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Daniel Paredes-Sabja, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-24-33067R3 PLOS ONE Dear Dr. Barua, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Daniel Paredes-Sabja Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .